UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063031
Receipt number R000072153
Scientific Title Effects of 4-week continuous intake of mineral-rich water on skin condition and advanced glycation end products: a randomized staggered-start intervention study
Date of disclosure of the study information 2026/09/23
Last modified on 2026/09/23 18:06:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of 4-week continuous intake of mineral-rich water on skin condition and glycation-related indices

Acronym

Mineral Water Skin and Glycation Study

Scientific Title

Effects of 4-week continuous intake of mineral-rich water on skin condition and advanced glycation end products: a randomized staggered-start intervention study

Scientific Title:Acronym

Mineral Water Skin Aging Study

Region

Japan


Condition

Condition

Age-related changes in skin condition and glycation-related indices

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to examine the effects of 4 weeks of continuous intake of mineral-rich water on skin condition and glycation-related indices associated with advanced glycation end products (AGEs) in women aged 50-69 years. Each participant will complete a 4-week control period during which usual lifestyle is maintained, followed by a 4-week mineral-water intervention period. Changes during the control and intervention periods will be compared within participants. Participants will be assigned to one of two groups with study initiation staggered by 2 weeks.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The primary outcome is the difference between the change in the glycation-related index associated with AGEs during the 4-week control period and the change during the subsequent 4-week mineral-water intervention period. Measurements will be performed at weeks 0, 4, and 8 for each participant. Control-period change: week 4 minus week 0. Intervention-period change: week 8 minus week 4. The primary analysis will compare the changes during the control and intervention periods within participants.

Key secondary outcomes

Secondary outcomes include skin texture, skin brightness, skin spots, skin aging-related indices, and skin moisture. Each outcome will be assessed at weeks 0, 4, and 8. Changes during the 4-week control period and the subsequent 4-week mineral-water intervention period will be calculated and compared within participants.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

[Group A: Earlier-start group] Participants will maintain their usual diet, fluid intake, physical activity, and lifestyle for the first 4 weeks without consuming the study mineral water. No additional restriction or prescribed intake of ordinary drinking water will be imposed. After the 4-week control period, participants will consume the study mineral-rich water continuously for 4 weeks while maintaining their usual lifestyle. Skin condition and the glycation-related index associated with AGEs will be assessed at baseline, week 4, and week 8. Both groups undergo the identical control and intervention periods; only the study start timing differs by 2 weeks between groups. Planned start date: September 24, 2026. Planned end date: around November 19, 2026.

Interventions/Control_2

[Group B: Later-start group] Participants will begin the study 2 weeks after Group A. Participants will maintain their usual diet, fluid intake, physical activity, and lifestyle for the first 4 weeks without consuming the study mineral water. No additional restriction or prescribed intake of ordinary drinking water will be imposed. After the 4-week control period, participants will consume the study mineral-rich water continuously for 4 weeks while maintaining their usual lifestyle. Skin condition and the glycation-related index associated with AGEs will be assessed at baseline, week 4, and week 8. Both groups undergo the identical control and intervention periods; only the study start timing differs by 2 weeks between groups. Planned start date: October 8, 2026. Planned end date: around December 3, 2026.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

69 years-old >=

Gender

Female

Key inclusion criteria

1. Women aged 50-69 years
2. Individuals who understand the study procedures and provide written informed consent
3. Individuals who are able to continuously consume the specified mineral-rich water for 4 weeks
4. Individuals who are able to participate in the scheduled assessments during the study period
5. Individuals who are able to maintain their usual lifestyle during the study period

Key exclusion criteria

1. Individuals with a disease, allergy, or other health condition considered incompatible with consumption of the study product
2. Individuals planning to initiate new treatment, health foods, or supplements during the study period that may substantially affect skin condition or glycation-related indices
3. Individuals who are unable to comply with the specified intake procedure or assessment schedule
4. Individuals judged by the principal investigator or co-investigators to be inappropriate for participation in the study

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Shiho
Middle name
Last name Kurosaka

Organization

Hiroshima University

Division name

Graduate School of Humanities and Social Sciences

Zip code

739-8524

Address

1-1-1 Kagamiyama, Higashi-Hiroshima City, Hiroshima 739-8524, Japan

TEL

082-424-6844

Email

shihok@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Shiho
Middle name
Last name Kurosaka

Organization

Hiroshima University

Division name

Graduate School of Humanities and Social Sciences

Zip code

739-8524

Address

1-1-1 Kagamiyama, Higashi-Hiroshima City, Hiroshima 739-8524, Japan

TEL

082-424-6844

Homepage URL


Email

shihok@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

JES Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research Ethics Committee, Graduate School of Humanities and Social Sciences, Hiroshima University

Address

1-1-1 Kagamiyama, Higashi-Hiroshima City, Hiroshima 739-8524, Japan

Tel

082-424-6705

Email

shihok@hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

広島大学(広島県)
Hiroshima University (Hiroshima, Japan)


Other administrative information

Date of disclosure of the study information

2026 Year 09 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 09 Month 23 Day

Date of IRB

2026 Year 01 Month 08 Day

Anticipated trial start date

2026 Year 09 Month 24 Day

Last follow-up date

2026 Year 12 Month 03 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is conducted under a collaborative research agreement between Hiroshima University and JES Co., Ltd. JES Co., Ltd. provides research funding and the mineral-rich water used as the study product but has no role in the study design, participant recruitment or allocation, conduct of the intervention, measurements, data collection or management, statistical analysis, or interpretation of the results.


Management information

Registered date

2026 Year 09 Month 23 Day

Last modified on

2026 Year 09 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072153